Virtual reality to boost neuroplasticity in children and adolescents
Official title: M.I.N.E.R.V.A., Metodologie Innovative Per la Neuroplasticità in Età Evolutiva Con l'Uso Della Realtà Virtuale a Scopo Abilitativo
Run by IRCCS Centro Neurolesi Bonino Pulejo · NCT07426315 · Data updated 2026-11-12
This project will try immersive virtual reality rehabilitation to improve attention, motor skills, social interaction, and quality of life in children and teens aged 8–18 with ADHD, autism, or cerebral palsy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 8 Years to 18 Years |
| Sex | All |
| Enrollment | 108 (estimated) |
| Sponsor | IRCCS Centro Neurolesi Bonino Pulejo Academic / other |
| Locations | 1 site (Messina, Messina) |
| Status | Recruiting |
| Started | August 14, 2025 |
| Main results expected | January 2028 |
| Study ends | August 2028 |
| Registry record updated | February 23, 2026 |
| Trial ID | NCT07426315 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children and adolescents aged 8–18 with a clinical diagnosis of ADHD, ASD, or cerebral palsy who can follow instructions and have sufficient cognitive and motor abilities to use the IVR system are ideal candidates.
✕Probably not a fit
Children with severe cognitive or intellectual disability, uncontrolled epilepsy, major psychiatric disorders, or severe motor impairments that prevent use of the IVR platform are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study enrolls children and adolescents aged 8–18 with diagnoses of ADHD, ASD, or cerebral palsy and delivers immersive virtual reality (IVR) rehabilitation using the CAREN platform alongside conventional interventions. Participants complete a course of IVR sessions designed to target cognitive, motor, and social skills with baseline and follow-up assessments of attention, motor function, social interaction, and quality of life. Outcomes from the IVR program will be compared with standard rehabilitation approaches to see if IVR yields greater engagement and broader functional gains. Safety, tolerability, and the feasibility of integrating IVR into pediatric rehabilitation are also recorded.
Why it matters
Potential benefit: If successful, IVR rehabilitation could make therapy more engaging and produce measurable gains in attention, movement, social interaction, and overall quality of life for affected children.
How similar studies have gone: Smaller and observational studies have reported promising engagement and functional gains with virtual reality in pediatric neurorehabilitation, but large randomized trials are still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children and adolescents aged 8 to 18 years * Diagnosis of one of the following neurodevelopmental disorders: * Attention Deficit Hyperactivity Disorder (ADHD) * Autism Spectrum Disorder (ASD) * Cerebral Palsy (CP) * Ability to understand and comply with instructions for the intervention * Adequate cognitive, motor, and social skills to participate in the rehabilitation program * Informed consent obtained from a parent or legal guardian Exclusion Criteria: * Children and adolescents younger than 8 or older than 18 years * Severe cognitive impairments or intellectual disabilities that prevent participation in the rehabilitation program * Diagnosis of conditions not related to the target neurodevelopmental disorders, such as: * Major psychiatric disorders (e.g., severe depression, schizophrenia) * Neurological disorders not included in the study (e.g., epilepsy) * Severe motor impairments that prevent interaction with the virtual reality platform * Uncontrolled medical conditions (e.g., severe cardiovascular, respiratory, or endocrine diseases) * Lack of informed consent from a parent or legal guardian * Participation in another intervention or study that may interfere with the rehabilitation program * Behavioral issues or extreme anxiety that make it impossible to follow instructions or interact with the virtual reality system
Where it's running
-
IRCCS Neurolesi Bonino Pulejo
Messina, Messina, Italy Recruiting
Study contacts
- Study coordinator: Francesca Cucinotta
- Email: francesca.cucinotta@irccsme.it
- Phone: 09060128256
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding brain development in congenital hypothyroidism: comparing affected children, healthy controls, and mild thyroid conditions
This study tests how brain development in children with congenital hypothyroidism compares to similar children without the condition and to kids with a mild thyroid finding.
-
Leopard: using multi-omics to boost genetic diagnosis for neurodevelopmental disorders
This study tests a multi-omics approach to find genetic explanations for neurodevelopmental disorders in people with moderate-to-severe intellectual disability.
-
Melillo Method for kids with behavior and learning challenges
This pilot test will see if the Melillo Method can be feasibly delivered in two Illinois schools to help kids aged 8 and up who have behavioral and learning difficulties.
-
Understanding how sensory brain signals vary in people with and without neurodevelopmental disorders
This study tests whether people with neurodevelopmental disorders show more variation in brain responses to sensory stimulation than people without these disorders.
-
Two-week intensive brain-focused therapy program for children with neurodevelopmental and chromosomal conditions
This program will try a two-week, individualized multimodal neurorehabilitation approach for children about 4–12 years old with neurodevelopmental or chromosomal conditions to see if it improves attention, motor skills, communication, and daily functioning.
-
Social cognition testing for 8–16-year-olds with autism, ADHD, or atypical development
This project will test a multidimensional social-cognition battery in French-speaking 8–16-year-olds with autism, ADHD, or atypical neurodevelopment to see if it better identifies social processing differences.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.